IndexIQ Advisors’s NEOPHOTONICS CORP NPTN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$1.4M Sell
92,317
-49,173
-35% -$749K 0.05% 243
2021
Q4
$2.17M Buy
141,490
+103,867
+276% +$1.37M 0.07% 219
2021
Q3
$328K Buy
37,623
+3,768
+11% +$34.4K 0.01% 955
2021
Q2
$346K Sell
33,855
-2,206
-6% -$23.3K 0.01% 917
2021
Q1
$431K Buy
+36,061
New +$409K 0.02% 421

Other funds holding NPTN

IndexIQ Advisors's NPTN Position: Q1 2022 in Review

IndexIQ Advisors reduced its NEOPHOTONICS CORP (NPTN) stake by 35% in Q1 2022, selling an estimated $749K and leaving 92,317 shares worth $1.4M. The position accounts for 0.05% of the portfolio, ranked #243.

IndexIQ Advisors first reported a position in NPTN in Q1 2021 and has held it in 5 quarters since. The position peaked at $2.17M in Q4 2021. 143 funds tracked by Wall St. Rank hold NPTN as of Q1 2022.

  • IndexIQ Advisors held 92,317 shares of NEOPHOTONICS CORP worth $1.4M as of Q1 2022.
  • IndexIQ Advisors sold 49,173 NEOPHOTONICS CORP shares in Q1 2022, an estimated $749K.
  • NEOPHOTONICS CORP made up 0.05% of IndexIQ Advisors's portfolio in Q1 2022, its #243 holding.
  • IndexIQ Advisors first reported a position in NEOPHOTONICS CORP in Q1 2021 and has held it in 5 quarters since.
  • IndexIQ Advisors's NEOPHOTONICS CORP position peaked at $2.17M in Q4 2021.
  • 143 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q1 2022.

Based on IndexIQ Advisors's 13F filing for Q1 2022, filed 6 May 2022.